NeuroFlow is a HIPAA-compliant cloud-based platform that empowers health care providers to objectively track, assess, and engage patients using evidence-based practices to support their mental health.

NeuroFlow is committed to promoting behavioral health access across the care continuum.

NeuroFlow was founded in 2017 Christopher Molaro and Adam Pardes. The company is headquartered in Philadelphia, Pennsylvania.


NeuroFlow’s suite of HIPAA-compliant, cloud-based tools simplify remote patient monitoring and behavioral health integration across the continuum of care, including psychology, primary care, and pain management settings.


NeuroFlow's cloud-based platform allows healthcare providers to track, assess and connect with patients between traditional office visits. The company also offers AI-driven clinical decision support with recommendations for the next steps for individual patients.


NeuroFlow has forged partnerships with CirrusMD and Aflac. NeuroFlow has a user base of over 500,000 in support of nearly 270 commercial health systems, payers, accountable care organizations, independent medical groups, and federal agencies.


NeuroFlow is backed by Magellan Health, SEMCAP Health, Builders VC, Dreamit Ventures, Spring Point Partners, Red & Blue Ventures, and others. The company raised $25M in a new round on Oct 13, 2022. This brings NeuroFlow's total funding to $57M to date.



  • Year founded: 2017
  • Funding Info: $57M over 5 Rounds (Latest Funding Type: Series C)
  • Yearly Revenue: NA
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: Philadelphia
  • State: Pennsylvania
  • Country: United States
Related businesses